Right ventricular infarction: specific requirements of management

L G Horan1, N C Flowers

  • 1Department of Veterans Affairs Medical Center, Augusta, Georgia, USA.

American Family Physician
|October 28, 1999
PubMed

Insights

Right ventricular infarction, caused by right coronary artery occlusion, presents with distinct ECG changes and risks. Early recognition and management, including reperfusion and hemodynamic support, are crucial for patient outcomes.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pathophysiology

Background:

  • Right ventricular infarction (RVI) is primarily caused by atherosclerotic proximal occlusion of the right coronary artery.
  • Proximal occlusion leads to electrocardiographically identifiable right-heart ischemia, increasing mortality risk in acute inferior infarction.

Purpose of the Study:

  • To detail the clinical recognition, hemodynamic effects, and management strategies for right ventricular infarction.

Main Methods:

  • Electrocardiographic analysis to identify inferior left ventricular and right ventricular ischemia.
  • Assessment of associated findings like atrial infarction, bradycardia, and heart block.
  • Evaluation of hemodynamic effects, including systemic hypotension due to right ventricular dysfunction.

Main Results:

  • ECG findings include ST elevation in leads II, III, aVF (inferior ischemia) and V3R-V6R (right ventricular ischemia), with ST depression in V2-V4.
  • Associated findings can include atrial infarction, sinus bradycardia, AV node block, and atrial fibrillation.
  • Right ventricular dysfunction can lead to insufficient pulmonary blood flow and systemic hypotension.

Conclusions:

  • Prompt recognition of RVI through characteristic ECG manifestations is essential.
  • Management focuses on reperfusion, volume loading, rate/rhythm control, and inotropic support to address hemodynamic compromise.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...